mitomycin C: Clinical Trials

9 trials of mitomycin C, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Terminated 9
Phase 32Terminated 2

Follow mitomycin C: new trials by email Literature Review of mitomycin C trials Research Report on mitomycin C

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
CG0070 Adenovirus Vector, Control Arm: Quadruple Choice - Transitional Cell Carcinoma, Bladder Cancer
Phase 2 / Phase 3TerminatedCG Oncology, Inc.222014-03-012021-04-14
Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer
ifosfamide, mitomycin C - Pancreatic Cancer
Phase 2TerminatedIRCCS San Raffaele212006-03-012012-02-01
A Study of Mitomycin C, Irinotecan, and Cetuximab
Mitomycin C, Cetuximab, Irinotecan. - Colorectal Cancer
Phase 2TerminatedUniversity of Michigan Rogel Cancer Center132005-12-012015-12-03
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
cetuximab, capecitabine, docetaxel - Pancreatic Cancer
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins2492005-10-012018-10-24
Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
mitomycin C - Metastatic Cancer
Phase 2TerminatedMasonic Cancer Center, University of Minnesota12004-08-012017-11-29
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
cisplatin, fluorouracil, mitomycin C - Anal Cancer
Phase 2 / Phase 3TerminatedEuropean Organisation for Research and Treatment of Cancer - EORTC882003-07-012012-09-24
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
sargramostim, cisplatin, dacarbazine - Sarcoma
Phase 2TerminatedGynecologic Oncology Group2002-03-012013-04-11
Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
chemotherapy, fluorouracil, leucovorin calcium - Colorectal Cancer, Metastatic Cancer
Phase 2TerminatedUNICANCER1999-07-012021-02-17
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
cisplatin, doxorubicin hydrochloride, mitomycin C - Sarcoma
Phase 2TerminatedGynecologic Oncology Group301997-08-012013-07-09

Conditions studied

Colorectal Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Pancreatic Neoplasms (2)  ·  Sarcoma (2)  ·  Adenoviridae Infections (1)  ·  Anus Neoplasms (1)  ·  Carcinoma in Situ (1)  ·  Carcinoma, Transitional Cell (1)  ·  Colonic Neoplasms (1)  ·  Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)  ·  Virus Diseases (1)

Sponsors

Gynecologic Oncology Group (2)  ·  CG Oncology, Inc. (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  IRCCS San Raffaele (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  UNICANCER (1)  ·  University of Michigan Rogel Cancer Center (1)

Countries

United States (6)  ·  Belgium (2)  ·  France (2)  ·  Italy (2)  ·  Egypt (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Serbia (1)

Top investigators

Alex W Yeung, MBBS (1)  ·  Daniel A. Laheru, MD (1)  ·  Dominique Elias, MD (1)  ·  Harry J. Long, MD (1)  ·  Jean-Francois Bosset, MD (1)  ·  John H. Edmonson, MD (1)  ·  Mark Zalupski, M.D. (1)  ·  Michele Reni, MD (1)  ·  Todd M. Tuttle, MD (1)

Results publications

PMID 12051882, PMID 16051328, PMID 19643599, PMID 21135251

NIH funding

P30CA006973 (1)